Trial Profile

Safety and efficacy study using ABT-335 [Choline fenofibrate] (investigational drug) in combination with atorvastatin, to study the effects on thickening of the blood vessel wall in patients with abnormal lipid (fat) levels in the blood (FIRST).

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 04 Jul 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

10 Mar 2013 Primary endpoint 'Intima-media-thickness' has not been met.
10 Mar 2013 Results presented at the 62nd Annual Scientific Session of the American College of Cardiology.
01 Sep 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com